Understanding what does rh factor do begins with recognizing that it is a specific protein present on the surface of red blood cells. This inherited trait, named after the rhesus monkey where it was first identified, acts as a crucial biological marker that determines compatibility in blood transfusions and plays a vital role in pregnancy. While the ABO system classifies blood into groups like A, B, AB, and O, the rh factor—positive or negative—adds a second layer of classification essential for medical safety.
The Biological Mechanism of Rh
The primary question of what does rh factor do is answered by its function as an antigen. When the Rh protein is present, the blood type is positive; when absent, it is negative. This distinction is not merely academic, as the immune system treats the Rh-negative marker as foreign if it encounters Rh-positive blood. This immune response can lead to the production of antibodies designed to attack and destroy these "invader" cells, a process that underpins the critical medical concerns associated with rh incompatibility.
Rh Factor in Blood Transfusions
One of the most direct answers to what does rh factor do is observed during blood transfusions. Receiving a transfusion with the wrong rh factor is dangerous because the recipient's body may immediately recognize the new cells as threats. For an Rh-negative individual receiving Rh-positive blood, the immune system creates antibodies that can cause a severe reaction known as a hemolytic transfusion. This is why blood donations are always typed and matched for both the ABO group and the rh factor to ensure safety.
Rh Incompatibility and Pregnancy
How Pregnancy Triggers Immune Responses
When considering what does rh factor do, the most significant implications arise during pregnancy. If an Rh-negative woman carries an Rh-positive baby—often inherited from the father—their blood systems rarely mix during the first delivery. However, during childbirth or certain medical procedures, fetal blood can enter the mother's bloodstream. This event causes the mother's body to produce anti-D antibodies, a process called sensitization, which usually does not affect the current pregnancy but poses severe risks for future pregnancies.
Preventing Hemolytic Disease of the Newborn
The danger of this sensitization manifests in subsequent pregnancies. If the mother becomes pregnant again with another Rh-positive child, her pre-existing antibodies can cross the placenta and attack the fetus's red blood cells. This condition, known as Hemolytic Disease of the Newborn (HDN), can lead to anemia, jaundice, or even heart failure in the infant. Modern medicine effectively manages this risk through a preventative treatment called RhoGAM, an injection given to the mother to halt antibody production.
Who Needs RhoGAM and When
To fully grasp what does rh factor do in a clinical setting, one must understand the timeline of RhoGAM administration. This anti-D immunoglobulin is typically given around the 28th week of pregnancy and again within 72 hours after delivery if the baby is Rh-positive. It is also administered after events like miscarriages, amniocentesis, or abdominal trauma during pregnancy. By binding to any fetal Rh-positive cells that entered the mother's bloodstream, the injection prevents her immune system from recognizing them and mounting a permanent defensive response.
Global Prevalence and Genetic Inheritance
The distribution of the rh factor varies significantly across different ethnic groups and geographies. Approximately 85% of people are Rh-positive, leaving 15% as Rh-negative. This trait is genetic; if both parents are negative, the child will be negative. However, if one parent is positive and the other negative, the child could inherit either trait. Understanding these statistics is crucial for family planning and for medical professionals assessing the risk of incompatibility during prenatal care.
